Stefan Barta
Director, T-Cell Lymphoma Program, UPenn · University of Pennsylvania Health System
Credentials: · · · · · ·
History
- 2008–2011
- 2005–2008
- 2002–2005
- 1999–2002
Research
Blood · 2014 · 391 citations
Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment
Review · American Journal of Hematology · 2019 · 372 citations
Review · American Journal of Hematology · 2021 · 293 citations
40 papers · 1 as a fellow
39 papers
38 papers
34 papers
33 papers
32 papers
29 papers
28 papers · 1 as a fellow
Grants
- 2025–2029
Food and Drug Administration · R01
Contact PI · $3.4M · University of Pennsylvania
Clinical trials
- 2026–2030
Site PI · Recruiting · Phase 1
Kyowa Kirin, Inc.
- 2024–2028
- 2021–2027
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Site PI · Recruiting · Phase 2
Alliance for Clinical Trials in Oncology
- 2021–2030
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
Site PI · Recruiting · Early phase 1
AIDS Malignancy Consortium